EG270499 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
AMP-activated protein kinase (AMPK) activator that indirectly inhibits Gm5058. A-769662 activates AMPK, which negatively regulates mTORC1 through phosphorylation, modulating downstream signaling and indirectly impacting Gm5058 expression. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
GSK-3 inhibitor that indirectly influences Gm5058. By inhibiting GSK-3, SB-216763 disrupts the Wnt signaling pathway, altering downstream elements. This perturbation indirectly affects Gm5058 expression, showcasing the intricate crosstalk between signaling pathways. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $102.00 $138.00 | 14 | |
AKT inhibitor affecting the PI3K/AKT pathway. Triciribine disrupts the signaling cascade, potentially modulating Gm5058 expression through PI3K/AKT-dependent mechanisms, showcasing the interconnectivity of pathways in cellular regulation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB inhibitor influencing inflammatory pathways. BAY 11-7082 modulates NF-κB activity, indirectly affecting Gm5058 expression due to the intricate connection between inflammatory responses and cellular regulatory networks. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor disrupting the PI3K/AKT pathway. Wortmannin alters downstream signaling, potentially impacting Gm5058 expression through indirect modulation of the PI3K/AKT-dependent regulatory mechanisms, highlighting the complexity of intracellular signaling networks. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor impacting the mTORC1 pathway. Rapamycin disrupts mTORC1 signaling, indirectly influencing Gm5058 expression through the intricate interplay between mTORC1 and downstream effectors, emphasizing the multifaceted nature of cellular regulatory networks. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor affecting the JNK pathway. SP600125 modulates JNK signaling, potentially altering Gm5058 expression through the intricate crosstalk between the JNK pathway and downstream cellular processes, underscoring the complexity of regulatory networks in cellular biology. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor influencing the PI3K/AKT pathway. LY294002 disrupts PI3K signaling, potentially modulating Gm5058 expression through the intricate regulation of downstream effectors within the PI3K/AKT pathway, highlighting the nuanced connectivity of cellular signaling networks. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor affecting the MAPK pathway. PD98059 disrupts MAPK signaling, potentially impacting Gm5058 expression through modulation of downstream effectors. The interplay between the MAPK pathway and Gm5058 underscores the intricate regulatory mechanisms within cellular networks. | ||||||
SP2509 | 1423715-09-6 | sc-492604 | 5 mg | $284.00 | ||
LSD1 inhibitor affecting histone modification. SP2509 modulates epigenetic regulation, potentially influencing Gm5058 expression through altered histone modifications. The connection between epigenetic modulation and Gm5058 emphasizes the role of chromatin dynamics in gene regulation. | ||||||